trending Market Intelligence /marketintelligence/en/news-insights/trending/zkvJGTqSVtJGz-DWNihw-w2 content esgSubNav
In This List

Karo Pharma closes offer to acquire Weifa shares

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Karo Pharma closes offer to acquire Weifa shares

Karo Pharma AB (publ) closed its voluntary offer to acquire all shares of Weifa ASA.

With 35,453,352 shares transferred to Karo Pharma, the company now holds 97.21% of the shares and voting rights in Weifa.

Karo Pharma will now effect a compulsory acquisition of the remaining shares in Weifa at 35 Norwegian kroner apiece as soon as possible.

As of Oct. 5, US$1 was equivalent to 7.99 Norwegian kroner.